Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment
NCT06085183
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Ureter Injury
Interventions
OTHER:
Saline Injection 0.9%
DRUG:
Indigotindisulfonate sodium 0.8%
Sponsor
Prove pharm